HAL-MPE1

N/A

Report date: 2022/07/29 20:00:35

Base Information

Drug NameHAL-MPE1
Drug Alias Name่Šฑ็”Ÿ่ฟ‡ๆ•ๅ…็–ซ็–—ๆณ•Peanut extractPeanut allergy vaccine่Šฑ็”Ÿ่ฟ‡ๆ•็–ซ่‹—Peanut allergy immunotherapy +[6]ย 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPeanut Hypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHal Allergy
China Registration ClassN/A

Develop Information

Active CompaniesAllergy Therapeutics
Inactive CompaniesHal Allergy
Active IndicationsPeanut Hypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A